Evidence map›Paper›PMID 33239790›Full record

ArticleNature2020

The gut microbiota is associated with immune cell dynamics in humans.

Jonas Schluter, Jonathan U Peled, Bradford P Taylor, Kate A Markey, Melody Smith, Ying Taur, Rene Niehus, Anna Staffas, Anqi Dai, Emily Fontana and 14 more

3 registry-linked trialsAbstract read
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 359 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
359citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06802406 narecruitingnot on this mapstarted 2025, after this paper: background citation

Nutrition OUtReach In Systems of Healthcare

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2025 to 2029Enrolled210ConditionsALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Autologous Haemopoietic Stem Cell Transplant, CAR-T Cell Therapy, Food InsecurityArmsFood Bags
NCT06953648 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2025 to 2030Enrolled126ConditionsHematopoietic Stem Cell Transplantation, Cardiorespiratory FitnessArmsHigh Intensity Interval Training
NCT07640633 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Fecal Microbiota Transplantation for Feeding Intolerance Due to Gastrointestinal Dysfunction in Critically Ill Patients: A Single-Center, Single-Blind, Randomized Controlled Trial

TypeinterventionalSponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyRan2026 to 2027Enrolled60ConditionsFeeding Intolerance, Gastrointestinal Dysfunction, Critically Ill Intensive Care Unit PatientsArmsFecal microbiota transplantation (FMT)
3 · Its place in the literature

Who cites it

359 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Article
  11. Gut microbiota associate with disease severity and survival in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine · 2026
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. A tumor-residentiScience · 2026
    Article
  19. Review
  20. Alteration of small intestinal microbiota in diet-induced steatohepatitis mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article

299 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Jonas SchluterInstitute for Computational Medicine, NYU Langone Health, New York, NY, USA. jonas.schluter@nyulangone.org.ORCID http://orcid.org/0000-0002-6214-9367
Jonathan U PeledAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4029-7625
Bradford P TaylorComputational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kate A MarkeyAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Melody SmithAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-2702-0381
Ying TaurInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.
Rene NiehusHarvard University, T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6751-4124
Anna StaffasSahlgrenska Cancer Center, Department of Microbiology and Immunology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Sweden.
Anqi DaiAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emily FontanaInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.
Luigi A AmorettiInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.
Roberta J WrightInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.
Sejal MorjariaInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.
Maly FenelusDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Melissa S PessinDepartment of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-3990-6494
Nelson J ChaoDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Meagan LewDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Lauren BohannonDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Amy BushDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Anthony D SungDivision of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, USA.
Tobias M HohlInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.ORCID http://orcid.org/0000-0002-9097-5412
Miguel-Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5910-4571
Marcel R M van den BrinkAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-0696-4401
Joao B XavierComputational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. xavierj@mskcc.org.ORCID http://orcid.org/0000-0003-3592-1689

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
T LYMPHOCYTE SUBSET FUNCTION POST-TRANSPLANTATIONP01CA023766 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PERALES, MIGUEL-ANGEL · 1985 to 2023
$59.0M
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesisU54CA209975 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S, RUDENSKY, ALEXANDER Y · 2016 to 2021
$11.8M
Systems Biology of Microbiome-mediated Resilience to Antibiotic-resistant PathogensU01AI124275 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI PAMER, ERIC G., XAVIER, JOAO · 2016 to 2020
$8.9M
The role of intestinal microbiota in graft-versus-host diseaseR01CA228308 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Philip L Lorenzi, Marcel R M van den Brink · 2018 to 2026
$5.2M
INITIATION OF THE IMMUNE RESPONSE TO ASPERGILLUS FUMIGATUSR01AI093808 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HOHL, TOBIAS M · 2011 to 2020
$4.9M
Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT)R01AI137269 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TAUR, YING, XAVIER, JOAO · 2019 to 2023
$3.8M
Patient-centered home-based hematopoietic stem cell transplantationR01CA203950 · NCI · DUKE UNIVERSITY · PI CHAO, NELSON J. · 2016 to 2020
$3.1M
Microbiota mechanisms and biomarkers in GVHDK08HL143189 · NHLBI · SLOAN-KETTERING INST CAN RESEARCH · PI PELED, JONATHAN · 2019 to 2023
$858k
NCI NIH HHS P01 CA023766NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA203950NCI NIH HHS R01 CA228308NCI NIH HHS U54 CA209975NHLBI NIH HHS K08 HL143189NIAID NIH HHS R01 AI093808NIAID NIH HHS R01 AI137269NIAID NIH HHS U01 AI124275Wellcome Trust
6 · The paper itself

Abstract

The gut microbiota influences development

Indexed as

Age FactorsBayes TheoremFecal Microbiota TransplantationFemaleGastrointestinal MicrobiomeHumansLeukocyte CountLeukocytesLymphocytesMonocytesNeutrophilsReproducibility of Results

Identifiers

PMID33239790
PMCPMC7725892

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.